Literature DB >> 24984897

Role of CCR2 in inflammatory conditions of the central nervous system.

Hannah X Chu1, Thiruma V Arumugam2, Mathias Gelderblom3, Tim Magnus3, Grant R Drummond4, Christopher G Sobey4.   

Abstract

CC chemokine receptor 2 (CCR2) plays important roles in extravasation and transmigration of monocytes under inflammatory conditions. CCR2 and its ligands have been extensively studied in a range of inflammatory diseases in the central nervous system (CNS), including multiple sclerosis, Alzheimer's disease and ischemic stroke. This brief review summarizes our current understanding of the physiologic and pathologic roles of CCR2, focusing on its involvement in CNS inflammatory diseases. There appears to be a rationale for exploring therapies involving CCR2 inhibition in multiple sclerosis and ischemic stroke, but there is also evidence for immunomodulatory and protective effects of CCR2 activity during CNS inflammation. The critical balance between protective and detrimental roles of CCR2-dependent recruitment of leukocytes must therefore be carefully examined to guide safe and effective development of any therapies involving CCR2 modulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24984897      PMCID: PMC4158674          DOI: 10.1038/jcbfm.2014.120

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  62 in total

Review 1.  Chemokines: immunology's high impact factors.

Authors:  C R Mackay
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Experimental autoimmune encephalomyelitis: CC chemokine receptor expression by trafficking cells.

Authors:  Andrzej R Glabinski; Bartosz Bielecki; Sage O'Bryant; Krzysztof Selmaj; Richard M Ransohoff
Journal:  J Autoimmun       Date:  2002-12       Impact factor: 7.094

3.  Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.

Authors:  Paula M Hughes; Peter R Allegrini; Markus Rudin; V Hugh Perry; Anis K Mir; Christoph Wiessner
Journal:  J Cereb Blood Flow Metab       Date:  2002-03       Impact factor: 6.200

4.  Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

Authors:  Don Mahad; Melissa K Callahan; Katherine A Williams; Eroboghene E Ubogu; Pia Kivisäkk; Barbara Tucky; Grahame Kidd; Gillian A Kingsbury; Ansi Chang; Robert J Fox; Matthias Mack; M Bradley Sniderman; Rivka Ravid; Susan M Staugaitis; Monique F Stins; Richard M Ransohoff
Journal:  Brain       Date:  2005-10-17       Impact factor: 13.501

5.  Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen.

Authors:  L A Tylaska; L Boring; W Weng; R Aiello; I F Charo; B J Rollins; R P Gladue
Journal:  Cytokine       Date:  2002-05-21       Impact factor: 3.861

6.  TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice.

Authors:  Shinya Takami; Masabumi Minami; Takahiro Katayama; Izumi Nagata; Shobu Namura; Masamichi Satoh
Journal:  J Cereb Blood Flow Metab       Date:  2002-07       Impact factor: 6.200

7.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

8.  CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease.

Authors:  S J Connor; N Paraskevopoulos; R Newman; N Cuan; T Hampartzoumian; A R Lloyd; M C Grimm
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

9.  Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains.

Authors:  Stefanie Gaupp; David Pitt; William A Kuziel; Barbara Cannella; Cedric S Raine
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

10.  CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.

Authors:  B T Fife; G B Huffnagle; W A Kuziel; W J Karpus
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

View more
  54 in total

Review 1.  Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.

Authors:  Alicia García-Culebras; Violeta Durán-Laforet; Carolina Peña-Martínez; Iván Ballesteros; Jesús M Pradillo; Jaime Díaz-Guzmán; Ignacio Lizasoain; María A Moro
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-21       Impact factor: 6.200

Review 2.  Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Authors:  Stefka Gyoneva; Richard M Ransohoff
Journal:  Trends Pharmacol Sci       Date:  2015-05-13       Impact factor: 14.819

Review 3.  Resolution of neuroinflammation: mechanisms and potential therapeutic option.

Authors:  Nikolaos Dokalis; Marco Prinz
Journal:  Semin Immunopathol       Date:  2019-11-08       Impact factor: 9.623

4.  miR-124-3p is a chronic regulator of gene expression after brain injury.

Authors:  Niina Vuokila; Katarzyna Lukasiuk; Anna Maria Bot; Erwin A van Vliet; Eleonora Aronica; Asla Pitkänen; Noora Puhakka
Journal:  Cell Mol Life Sci       Date:  2018-08-28       Impact factor: 9.261

5.  Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus.

Authors:  Nicholas H Varvel; Jonas J Neher; Andrea Bosch; Wenyi Wang; Richard M Ransohoff; Richard J Miller; Raymond Dingledine
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

6.  Role of B cells and the aging brain in stroke recovery and treatment.

Authors:  E B Engler-Chiurazzi; K L Monaghan; E C K Wan; X Ren
Journal:  Geroscience       Date:  2020-08-07       Impact factor: 7.713

Review 7.  Perspectives for Monocyte/Macrophage-Based Diagnostics of Chronic Inflammation.

Authors:  Julia Kzhyshkowska; Alexandru Gudima; Kondaiah Moganti; Alexei Gratchev; Alexander Orekhov
Journal:  Transfus Med Hemother       Date:  2016-03-15       Impact factor: 3.747

8.  CCR2 dependent neutrophil activation and mobilization rely on TLR4-p38 axis during liver ischemia-reperfusion injury.

Authors:  Peng Xu; Junbin Zhang; Hui Wang; Guoliang Wang; Cong-Yi Wang; Jinxiang Zhang
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

Review 9.  Cellular biology of fracture healing.

Authors:  Chelsea S Bahney; Robert L Zondervan; Patrick Allison; Alekos Theologis; Jason W Ashley; Jaimo Ahn; Theodore Miclau; Ralph S Marcucio; Kurt D Hankenson
Journal:  J Orthop Res       Date:  2018-11-30       Impact factor: 3.494

10.  Hypothalamic CCL2/CCR2 Chemokine System: Role in Sexually Dimorphic Effects of Maternal Ethanol Exposure on Melanin-Concentrating Hormone and Behavior in Adolescent Offspring.

Authors:  Guo-Qing Chang; Olga Karatayev; Viktoriya Halkina; Jonathan Edelstien; Estefania Ramirez; Sarah F Leibowitz
Journal:  J Neurosci       Date:  2018-09-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.